Rinvoq

wellnowdoctor
wellnowdoctor
11,437
0
Published 2020-05-04
Rinvoq represents the third janus kinase inhibitor marketed in the United States. Xeljanz and Olumiant preceded Rinvoq. All are indicated for treatment of moderate to severe rheumatoid arthritis. Humira will lose patent protection in America in 2023 and face stiff competition from biosimilars. Rinvoq will be heavily advertised by AbbVie since it faces severe deterioration in its $20 billion a year golden goose - Humira - the most revenue derived from any single drug.

While the company quotes the annual price for Rinvoq at about $59,000, an individual paying cash for Rinvoq at the pharmacy can expect the cost to approximate $90,000. Through a sleight of hand the company offers Rinvoq copay assistance to limit the out of pocket burden, shield the consumer from sticker shock and pass the financial liability to the insurance company. Of course this results in an ever increasing spiral of premiums for everyone.

Unquestionably Rinvoq provides significant improvement for many with rheumatoid arthritis. But unfortunately its relative place among the various options lacks study. Other therapies include methotrexate, hydroxychoroquine, sulfasalazine, Simponi, Enbrel, Remicade, Humira, Actemra and the other janus kinase or JAK inhibitors. Of course many individuals with mild rheumatoid arthritis do well with aspirin, ibuprofen or naproxen.

With the billions of dollars these drugs transfer to the pharmaceutical industry, a study comparing the various options would be greatly welcome. Too often advertising drives prescriptions. And it can be expected that some individuals with mild disease will receive Rinvoq when it is not indicated. By the way, methotrexate costs as little as $20 a month without any insurance or other gimmicks.
All Comments (17)
  • @yeni0527
    My daughter has been on rinvoq for RA for over a year after trying almost every available treatment for RA and it has changed our lives!!! Even her rheumatologist was surprised about how well she is doing!
  • @johnoverstreet2347
    What a fantastic video. These newer drugs are hundreds of times the cost of cheaper drugs but not remotely close to hundreds of times more effective. The ability to divert the consumers' attention away from the costs of these drugs is astounding and seems to be reflected in this comment section. This system is toxic.
  • @tracysmith2346
    Very interesting.... I start taking this when my blood work comes back. I’m very hopeful. I would love to have my life back.
  • @cf-kw5qo
    Thankyou , very informative . , I’m an RN , studying to become a medical coder and biller . I have RA AND AM ON Rinvoc .
  • @nesstOar
    Thank you for this valuable information.
  • @cf-kw5qo
    Have done well on Rinvoc , no flaring for 4 months , but was flaring a lot over the last 3 weeks .
  • @cf-kw5qo
    Was on Humira last year , still flared on it .
  • @evelynd
    Does it help with psoriasis and atopic dermatitis?
  • @cf-kw5qo
    It’s 87,ooo dollars now . Thankfully we paid prescriptions with our insurance .
  • @shackletonify
    Rinvoq did not work by me. And i have no options for treatment for my RA anymore.
  • @ryancurtis8737
    It is carcinogenic what the heck my dr literally went over that risk 2 in 100
  • @Krazzy2188
    Anyone worried about the cancer risks? Anyone else getting deep acne?? I've been on rinvoq for 3 weeks now.